Search

everythinglearnresearchcommunity

for

Search:↓

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Men with early hair loss have lower vitamin D levels.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

White hairs often regrow in alopecia areata patches.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

Interleukin-6 may play a role in causing alopecia areata.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Wigs greatly improve life quality for hair loss patients.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

Minoxidil injections can speed up hair regrowth in non-severe patchy hair loss, but combining it with steroids doesn't improve results.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.